A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease;Modelo de atención colaborativo entre cardiólogo y farmacéutico para mejorar la gestión de la hipertensión en pacientes con o en riesgo de enfermedad cardiovascular

Pharmacy Practice

Volumn 10, Issue 1, 2012, Pages 25-32

  Irons, Brian K ^a   Meyerrose, Gary ^b   Laguardia, Sherry ^b   Hazel, Kweku ^b   Seifert, Charles F ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood pressure; Cooperative behavior; Hypertension; Patient care team; Pharmacists; Physicians; United States

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGIST PHARMACIST COLLABORATIVE CARE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PULSE PRESSURE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 84858737759     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552012000100005     Document Type: Article

References (29)

1. American Heart Association. Heart disease and stroke statistics-2010 Update. Circulation. 2010;121:e46-e215.
2. Wong N, Lopez V, L'Italien G, Chen R, Kline S, Franklin S. Inadequate4 control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med. 2007;167(22):2431-2436.
3. Egan B, Zhao Y, Axon R. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-2050.
4. Law M, Morris J, Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta- analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
5. Rosendorff C, Black H, Cannon C, Gersh B, Gore J, Izzo J, Kaplan N, O'Connor C, O'Gara P, Oparil S. Treatment of hypertension in the prevention and management of ischemic heart disease. Circulation. 2007;115(21):2761-2788.
6. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560-2572.
7. Williams B, Poulter N, Brown M, Davis M, McInnes G, Potter J, Sever P, Thom S. British Hypertension Society Guidelines for hypertension management. BMJ. 2004;328:634-640.
8. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2002;21:1983-1992.
9. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. European Heart Journal. 2007;28:1462-1536.
10. Lipton H. Home is where the health is: Advancing team-based care in chronic disease management. Arch Intern Med. 2009;169(21):1945-1948
11. Walsh J, McDonald K, Shojania, Sundaram V, Nayak S, Lewis R, Owens D, Goldstein M. Quality improvement strategies for hypertension management. Med Care. 2006;44(7):646-657.
12. Robinson J, Segal R, Lopez L, Doty R. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44:88-96.
13. Carter B, Elliott W. The role of pharmacists in the detection, management, and control of hypertension: A national call to action. Pharmacotherapy. 2000;20(2):119-122.
14. Green B, Cook A, Ralston J, Fishman P, Catz S, Carlson J, Carrell D, Tyll L, Larson E, Thompson R. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care in hypertension control. JAMA. 2008;299(24):2857-2867.
15. Mehos B, Saseen J, MacLaughlin E. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20(11):1384-1389.
16. Carter B, Ardery G, Dawson J, James P, Bergus G, Doucette W, Chrischilles E, Franciscus C, Xu Y. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
17. Vivian E. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002:22(12):1533-1540.
18. Okamoto M, Nakahiro R. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21(11):1337-1344.
19. Bogden P, Abbott R, Williamson P, Onopa J, Koontz L. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998;13:740-745.
20. Borenstein J, Graber G, Saltiel E, Wallace J, Ryu S, Jackson A, Deutsch S, Weingarten S. Physician-pharmacist comanagement of hypertension: A randomized, comparative trial. Pharmacotherapy. 2003;23(2):209-216.
21. McConnell K, Zadvorny E, Hardy A, Delate T, Rasmussen J, Merenich J. Coronary artery disease and hypertension: Outcomes of a pharmacist-managed blood pressure program. Pharmacotherapy. 2006;26(9):1333-1341.
22. Turchin A, Goldberg S, Shubina M, Einbinder J, Conlin P. Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Hypertension. 2010;56(1):68-74.
23. Arguedas J, Perez M, Wright J. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev. 2009;(3):CD004349.
24. Cooper-DeHoff R, Gong Y, Handberg E, Bavry A, Denardo S, Bakris G, Pepine C. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304(1):61-68.
25. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.
26. Mancia G, Laurent S, Agabiti-Rosei, E, Ambrosioni E, Burnier M, Caulfield M, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heaferty A, Kjeldsen S, Kiowski W, Mallion J, Manolis A, Narkiewicz K, Nilsson P, Olsen M, Rahn K, Redon J, Rodicio J, Ruilope L, Schmeider R, Struijker-Boudier H, Va Zwieten P, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hyperten. 2009;27:2121-2158.
27. Carter B, Ogers M, Daly J, Zheng S, James P. The potency of team-based care interventions for hypertension. Arch Intern Med. 2009;169(19):1748-1755.
28. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788.
29. Vaccarino V, Holford T, Krumholz H. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol. 2000;36:130-138.